Over time, repeated movement of the facial skin by the muscles forms frown lines between the eyebrows. Wrinkles are not only age related. Frown lines are “dynamic”—they happen because of the way a person’s face moves. Because frown lines are created by facial movements such as frowning or squinting, they may develop even in younger adults. Dysport® is used to treat moderate to severe frown lines in adult patients less than 65 years of age. Dysport is basically the same as Botox® Cosmetic. The injection technique, duration of effect, etc., for all practical purposes, are the same.
The muscles above and between the eyebrows contract and tighten, and can cause wrinkles. Dysport® blocks the nerve signal that causes these facial muscles to contract. This ultimately results in a localized reduction of muscle activity in the treated area and temporarily stops the contraction of these muscles.
With just 1 injection into each of 5 points between and above the eyebrows, Dysport® blocks the signal from the nerve to the muscles, ultimately resulting in a reduction of muscle activity and temporarily preventing contraction of the muscles that cause frown lines.
The untreated facial muscles still contract normally, allowing you to freely show facial expressions, such as smiling, in untreated areas.
Give Yourself the Skin You Deserve
With Dysport®, often it’s only a 10-20 minute treatment. Ask your doctor about any precautions you should take after your treatment. Call your doctor or get medical help right away if you have any problems swallowing, speaking, or breathing. If this happens, do not drive a car, operate machinery, or do other dangerous activities.
In clinical trials, the efficacy of Dysport® was demonstrated with up to 4 repeated treatments. You should wait at least 90 days between treatments. The safety of Dysport® has been studied in up to 12 repeated treatments.
Dysport® is used for aesthetic purposes in 36 countries. In U.S. clinical trials, Dysport® was studied for safety in more than 2400 aesthetic patients. Of those, 769 participated in pivotal studies, with a subset of 376 evaluated for efficacy of Dysport®.